Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 14: - The adolescent who just can’t stay awake
Published online by Cambridge University Press: 03 April 2024
By
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
What is the impact of the selective serotonin–norepinephrine reuptake inhibitor (SNRI) venlafaxine (Effexor XR) on weight?
Keywords
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 227 - 248Publisher: Cambridge University PressPrint publication year: 2024
References
Fornaro, M, Anastasia, A, Valchera, A, et al. The FDA “Black Box” warning on antidepressant suicide risk in young adults: more harm than benefits? Front Psychiatry 2019; 10:294CrossRefGoogle ScholarPubMed
Hauri, P. Sleep Hygiene, Relaxation Therapy, and Cognitive Interventions. New York: Plenum, 1992.Google Scholar
Katz, LY, Kozyrskyj, AL, Prior, HJ, et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ 2008; 178:1005–11CrossRefGoogle ScholarPubMed
Lu, CY, Penfold, RB, Wallace, J, et al. Increases in suicide deaths among adolescents and young adults following US Food and Drug Administration antidepressant boxed warnings and declines in depression care. Psychiatric Res Clin Pract 2020; 2:43–52CrossRefGoogle Scholar
Messina, I, Sambin, M, Beschoner, P, et al. Changing views of emotion regulation and neurobiological models of the mechanism of action of psychotherapy. Cogn Affect Behav Neurosci 2016; 16:571–87CrossRefGoogle ScholarPubMed
Stahl, SM. Treatments for mood disorders: so-called “antidepressants” and “mood stabilizers. In Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5. Cambridge: Cambridge University Press, 2021, 283–358CrossRefGoogle Scholar
Stepanski, EJ, Wyatt, JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003; 7:215–25.CrossRefGoogle ScholarPubMed
Vollmer, C, Jankowski, KS, Díaz-Morales, JF, et al. Morningness–eveningness correlates with sleep time, quality, and hygiene in secondary school students: a multilevel analysis. Sleep Med 2017; 30:151–9.CrossRefGoogle Scholar